Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Foundation Medicine

Request full access

Transformation in cancer care, where each patient’s treatment is informed by a deep understanding of the molecular changes that contribute to their disease

Boston, United StatesFounded 2010Biotech & Life Sciences

At a glance

Status
Listed
Listing
IPO 2013

Foundation Medicine in the Boston ecosystem

Live from Dealroom

The Foundation Medicine office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

11 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

Series B and later9 investors entered at this stage

  • Harvard Medical School
  • Redmile Group
  • Harvard University
  • Bill Gates
  • Casdin Capital
  • Roche Venture Fund
  • Broad Institute
  • Evan Jones
  • Dana-Farber Cancer Institute
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Boston HQ
Book a demo for the full country breakdown

Patents

Estimated portfolio value
$92M

140 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where Foundation Medicine was the backer or acquirer, 2016–2026. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

3 deals across Foundation Medicine's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Foundation Medicine's portfolio, mapped.

        Stage
        Period
        3 of 3 deals

        See Foundation Medicine on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.